3 Year Absolute Returns
80.33% ↑
NAV (₹) on 18 Dec 2025
29.93
1 Day NAV Change
-0.20%
Risk Level
Very High Risk
Rating
-
Tata India Pharma & HealthCare Fund is a Equity mutual fund categorized under Sector, offered by Tata Asset Management Ltd.. Launched on 04 Dec 2015, investors can start with a minimum SIP of ₹100 or ... Read more
AUM
₹ 1,338.85 Cr
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 59.55% |
| Hospitals & Medical Services | 26.26% |
| Cash | 8.93% |
| Insurance Distributor | 1.68% |
| Fertilisers | 1.12% |
| Chemicals - Speciality | 0.82% |
| Medical Research Services | 0.56% |
| IT Enabled Services | 0.51% |
| Chemicals - Inorganic - Others | 0.29% |
| CBLO/Reverse Repo | 0.24% |
| Medical Equipment & Accessories | 0.04% |
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11.64% | ₹ 143.32 | Pharmaceuticals |
| CASH / NET CURRENT ASSET | 8.93% | ₹ 109.87 | Others |
| APOLLO HOSPITALS ENTERPRISE LTD | 6.22% | ₹ 76.55 | Hospitals & Medical Services |
| CIPLA LTD | 5.83% | ₹ 71.82 | Pharmaceuticals |
| AUROBINDO PHARMA LTD | 5.73% | ₹ 70.60 | Pharmaceuticals |
| DIVI LABORATORIES LTD | 5.63% | ₹ 69.40 | Pharmaceuticals |
| FORTIS HEALTHCARE LTD | 4.90% | ₹ 60.40 | Hospitals & Medical Services |
| LUPIN LTD | 4.82% | ₹ 59.37 | Pharmaceuticals |
| ASTER DM HEALTHCARE LTD | 4.35% | ₹ 53.52 | Hospitals & Medical Services |
| WOCKHARDT LTD | 3.27% | ₹ 40.28 | Pharmaceuticals |
| DR REDDYS LABORATORIES LTD | 3.16% | ₹ 38.98 | Pharmaceuticals |
| ALKEM LABORATORIES LTD | 3.11% | ₹ 38.37 | Pharmaceuticals |
| HEALTHCARE GLOBAL ENTERPRISES LTD | 2.93% | ₹ 36.13 | Hospitals & Medical Services |
| AJANTA PHARMA LTD | 1.93% | ₹ 23.79 | Pharmaceuticals |
| METROPOLIS HEALTHCARE LTD | 1.86% | ₹ 22.96 | Hospitals & Medical Services |
| TORRENT PHARMACEUTICALS LTD | 1.83% | ₹ 22.52 | Pharmaceuticals |
| KRISHNA INSTITUTE OF MEDICAL SCIENCES LTD | 1.82% | ₹ 22.41 | Hospitals & Medical Services |
| FDC LTD | 1.68% | ₹ 20.68 | Pharmaceuticals |
| MEDI ASSIST HEALTHCARE SERVICES LTD | 1.68% | ₹ 20.74 | Insurance Distributor |
| DR. LAL PATH LABS LTD | 1.66% | ₹ 20.40 | Hospitals & Medical Services |
| IPCA LABORATORIES LTD | 1.65% | ₹ 20.30 | Pharmaceuticals |
| INDOCO REMEDIES LTD | 1.36% | ₹ 16.72 | Pharmaceuticals |
| JUPITER LIFE LINE HOSPITALS LTD | 1.27% | ₹ 15.58 | Hospitals & Medical Services |
| DR. AGARWALS HEALTH CARE LTD | 1.25% | ₹ 15.41 | Hospitals & Medical Services |
| AKUMS DRUGS AND PHARMACEUTICALS LTD | 1.19% | ₹ 14.71 | Pharmaceuticals |
| COROMANDEL INTERNATIONAL LTD | 1.12% | ₹ 13.74 | Fertilisers |
| ZYDUS LIFESCIENCES LTD | 1.04% | ₹ 12.77 | Pharmaceuticals |
| AMI ORGANICS LTD | 0.96% | ₹ 11.76 | Pharmaceuticals |
| SANOFI INDIA LTD | 0.96% | ₹ 11.87 | Pharmaceuticals |
| MEDPLUS HEALTH SERVICES LTD | 0.93% | ₹ 11.48 | Pharmaceuticals |
| MANKIND PHARMA LTD | 0.83% | ₹ 10.23 | Pharmaceuticals |
| SANOFI CONSUMER HEALTHCARE INDIA LTD | 0.82% | ₹ 10.10 | Chemicals - Speciality |
| PROCTER & GAMBLE HEALTH LTD | 0.75% | ₹ 9.20 | Pharmaceuticals |
| GLAXOSMITHKLINE PHARMACEUTICALS LTD | 0.66% | ₹ 8.11 | Pharmaceuticals |
| ORCHID PHARMA LTD | 0.59% | ₹ 7.23 | Pharmaceuticals |
| SYNGENE INTERNATIONAL LTD | 0.56% | ₹ 6.92 | Medical Research Services |
| INVENTURUS KNOWLEDGE SOLUTIONS LTD | 0.51% | ₹ 6.28 | IT Enabled Services |
| DEEPAK NITRITE LTD | 0.29% | ₹ 3.63 | Chemicals - Inorganic - Others |
| REPO | 0.24% | ₹ 3 | Others |
| LAXMI DENTAL LTD | 0.04% | ₹ 0.55 | Medical Equipment & Accessories |
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 6.88% | -2.49% | 16.76% | 21.72% |
| Category returns | 12.61% | 0.69% | 15.54% | 26.16% |
The investment objective of the scheme is to seek long term capital appreciation by investing at least 80% of its net assets in equity/equity related instruments of the companies in the pharma & ... Read more
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Tata Equity Savings Fund - Regular Plan - Growth
Hybrid
Regular
|
₹56.32 | 5.68% | 32.36% | 52.60% | ₹277 | 1.13% |
Low to Moderate
|
|
Tata Equity Savings Fund - Regular Plan
Hybrid
Regular
|
₹26.98 | 5.68% | 32.36% | 52.50% | ₹277 | 1.13% |
Low to Moderate
|
|
Tata Equity Savings Fund - Regular Plan
Hybrid
Regular
|
₹26.98 | 5.68% | 32.36% | 52.50% | ₹277 | 1.13% |
Low to Moderate
|
|
Tata Retirement Savings Fund - Conservative Plan - Direct...
Hybrid
Direct
|
₹37.49 | 3.63% | 31.32% | 46.01% | ₹174 | 0.98% |
Moderately High
|
|
Tata Nifty Private Bank Exchange Traded Fund
ETF
Regular
|
₹292.38 | 12.34% | 30.54% | 71.38% | ₹12 | 0.20% |
Very High
|
|
Tata Retirement Savings Fund - Conservative Plan -...
Hybrid
Regular
|
₹31.86 | 2.40% | 26.74% | 37.61% | ₹174 | 2.17% |
Moderately High
|
|
Tata Corporate Bond Fund - Direct Plan
Income
Direct
|
₹12.96 | 7.52% | 25.88% | 0.00% | ₹4,304 | 0.31% |
Moderate
|
|
Tata Corporate Bond Fund - Direct Plan
Income
Direct
|
₹12.96 | 7.52% | 25.88% | 0.00% | ₹4,304 | 0.31% |
Moderate
|
|
Tata Corporate Bond Fund - Direct Plan
Income
Direct
|
₹12.96 | 7.52% | 25.88% | 0.00% | ₹4,304 | 0.31% |
Moderate
|
|
Tata Corporate Bond Fund - Direct Plan
Income
Direct
|
₹12.96 | 7.52% | 25.88% | 0.00% | ₹4,304 | 0.31% |
Moderate
|
What is the current NAV of Tata India Pharma & HealthCare Fund Regular IDCW-Reinvestment?
The current Net Asset Value (NAV) of Tata India Pharma & HealthCare Fund Regular IDCW-Reinvestment is ₹29.93 as of 18 Dec 2025. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.
What is the fund size (AUM) of Tata India Pharma & HealthCare Fund Regular IDCW-Reinvestment?
The Assets Under Management (AUM) of Tata India Pharma & HealthCare Fund Regular IDCW-Reinvestment is ₹1,338.85 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.
What are the historical returns of Tata India Pharma & HealthCare Fund Regular IDCW-Reinvestment?
Tata India Pharma & HealthCare Fund Regular IDCW-Reinvestment has delivered returns of -2.49% (1 Year), 21.72% (3 Year), 14.95% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.
What is the risk level of Tata India Pharma & HealthCare Fund Regular IDCW-Reinvestment?
Tata India Pharma & HealthCare Fund Regular IDCW-Reinvestment has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.
What is the minimum investment amount for Tata India Pharma & HealthCare Fund Regular IDCW-Reinvestment?
The minimum lumpsum investment required for Tata India Pharma & HealthCare Fund Regular IDCW-Reinvestment is ₹5,000. The fund also offers SIP (Systematic Investment Plan) option starting from as low as ₹150, making it accessible for regular investments. This allows investors to start their mutual fund journey with a manageable amount.
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article